Evidence map›Paper›PMID 25926836›Full record

ReviewFrontiers in immunology2015

Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation.

Ilaria Panzeri, Grazisa Rossetti, Sergio Abrignani, Massimiliano Pagani

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response.American journal of physiology. Cell physiology · 2021
    Review
  4. Article
  5. Review
  6. LncRNAs in ocular neovascularizations.International journal of ophthalmology · 2019
    Review
  7. Long noncoding RNAs in cancer-immunity cycle.Journal of cellular physiology · 2018
    Review
  8. The emerging role of long non-coding RNA in spinal cord injury.Journal of cellular and molecular medicine · 2018
    Review
  9. Review
  10. Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases.International journal of molecular sciences · 2016
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ilaria PanzeriIntegrative Biology Unit, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", IRCCS Ospedale Maggiore Policlinico , Milano , Italy.
Grazisa RossettiIntegrative Biology Unit, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", IRCCS Ospedale Maggiore Policlinico , Milano , Italy.
Sergio AbrignaniIntegrative Biology Unit, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", IRCCS Ospedale Maggiore Policlinico , Milano , Italy.
Massimiliano PaganiIntegrative Biology Unit, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", IRCCS Ospedale Maggiore Policlinico , Milano , Italy ; Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano , Milano , Italy.
Ospedale Maggiore · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituto Nazionale Genetica Molecolare · IT

Funding

European Research Council 269022European Research Council 617978
6 · The paper itself

Abstract

Upon recognition of a foreign antigen, CD4(+) naïve T lymphocytes proliferate and differentiate into subsets with distinct functions. This process is fundamental for the effective immune system function, as CD4(+) T cells orchestrate both the innate and adaptive immune response. Traditionally, this differentiation event has been regarded as the acquisition of an irreversible cell fate so that memory and effector CD4(+) T subsets were considered terminally differentiated cells or lineages. Consequently, these lineages are conventionally defined thanks to their prototypical set of cytokines and transcription factors. However, recent findings suggest that CD4(+) T lymphocytes possess a remarkable phenotypic plasticity, as they can often re-direct their functional program depending on the milieu they encounter. Therefore, new questions are now compelling such as which are the molecular determinants underlying plasticity and stability and how the balance between these two opposite forces drives the cell fate. As already mentioned, in some cases, the mere expression of cytokines and master regulators could not fully explain lymphocytes plasticity. We should consider other layers of regulation, including epigenetic factors such as the modulation of chromatin state or the transcription of non-coding RNAs, whose high cell-specificity give a hint on their involvement in cell fate determination. In this review, we will focus on the recent advances in understanding CD4(+) T lymphocytes subsets specification from an epigenetic point of view. In particular, we will emphasize the emerging importance of non-coding RNAs as key players in these differentiation events. We will also present here new data from our laboratory highlighting the contribution of long non-coding RNAs in driving human CD4(+) T lymphocytes differentiation.

Indexed as

epigenetic regulationlong non-coding RNAslymphocyte differentiation

Identifiers

PMID25926836
PMCPMC4397839
OpenAlexW2090320445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.